Genetic risks for type 2 diabetes span multiple ethnicities
A recent large and comprehensive analysis of 50,000 genetic variants across 2,000 genes linked to cardiovascular and metabolic function has identified four genes associated with type 2 diabetes (T2D) and six independent disease-associated ...
Diabetes
Feb 09, 2012 |
5 / 5 (2) |
0
|
Researchers pave the way for improving treatment for Type 2 diabetes
In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHU ...
Diabetes
Feb 07, 2012 |
5 / 5 (1) |
0
Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers ...
Medical research
Feb 07, 2012 |
3 / 5 (1) |
1
|
ACP recommends metformin to treat type 2 diabetes based on CE analysis of oral medications
The American College of Physicians (ACP) recommends that clinicians add metformin as the initial drug treatment for most patients with type 2 diabetes when lifestyle modifications such as diet, exercise, and weight loss have ...
Diabetes
Feb 06, 2012 |
not rated yet |
0
Amylin's long-delayed diabetes drug gets FDA nod
Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.
Diabetes
Jan 28, 2012 |
not rated yet |
0
Gardasil does not trigger autoimmune conditions after vaccination
Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes or multiple ...
Immunology
Jan 25, 2012 |
not rated yet |
0
Paper highlights need to identify and treat insomnia early to reduce risk of developing other illnesses
Insomnia is the most common sleep disorder, but despite advances in diagnosis and management it often goes unrecognised and untreated. Left untreated, insomnia increases the risk of developing other illnesses including depression, ...
Health
Jan 19, 2012 |
5 / 5 (1) |
0
Zebrafish may help speed drug discovery
Tiny zebrafish just may give scientists one solution to information overload in the search for new drugs therapies.
Medical research
Jan 17, 2012 |
not rated yet |
0
Added benefit of linagliptin is not proven
Linagliptin (trade name: Trajenta) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled ...
Medications
Jan 06, 2012 |
not rated yet |
0
Diabetes and obesity increase risk for breast cancer development
Having diabetes or being obese after age 60 significantly increases the risk for developing breast cancer, a Swedish study has revealed. Data also showed that high blood lipids were less common in patients when diagnosed ...
Cancer
Dec 07, 2011 |
not rated yet |
1
Andromeda Biotech: A drug for type 1 diabetes
The treated patients in the double-blinded study of DiaPep 277 showed significantly better pancreas function that the control group.
Diseases, Conditions, Syndromes
Nov 22, 2011 |
not rated yet |
0
Clot-busting drugs improve diabetic stroke patients' prospects, study reveals
(Medical Xpress) -- Clot-busting drugs given to patients who have diabetes and previously suffered a stroke aid their recovery from a second stroke a new study has revealed.
Medications
Nov 16, 2011 |
not rated yet |
0
Which diabetes drug is best for diabetics with kidney disease?
Some blood-sugar-lowering drugs have caused kidney problems in patients with type 2 diabetes, so physicians are especially cautious when prescribing these agents to diabetics who also have chronic kidney disease (CKD).
Diseases, Conditions, Syndromes
Nov 13, 2011 |
not rated yet |
0
British drugs firm GSK settles US drug disputes for $3.0 bln
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Medications
Nov 03, 2011 |
5 / 5 (1) |
0
FDA approves first diabetes-cholesterol combo pill
(AP) -- The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience - and savings - to patients taking multiple pills.
Medications
Oct 07, 2011 |
not rated yet |
0
